Nanjing Vishee Medical Technology Co Ltd (688580) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.79 Million ≈ $6.26 Million USD) by net assets (CN¥1.66 Billion ≈ $242.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 688580 live share price for real-time trading data and today's change.

Nanjing Vishee Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Nanjing Vishee Medical Technology Co Ltd (688580) market capitalisation for the company's overall valuation and market capitalisation.

Nanjing Vishee Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their cash flow conversion efficiency. Also see 688580 total asset value for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Fujian Zhangzhou Development Co Ltd SHE:000753	0.034x
Skipper Limited NSE:SKIPPER	0.092x
Tai-Tech Advanced Electronics Co Ltd TWO:3357	0.022x
Shanghai Smith Adhesive New SHG:603683	0.024x
Shanghai Laiyifen Co Ltd SHG:603777	0.040x
San Bian Science & Technology Co Ltd SHE:002112	-0.116x
Bajaj Consumer Care Limited NSE:BAJAJCON	0.105x
Udemy Inc NASDAQ:UDMY	0.074x

Annual Cash Flow Conversion Efficiency for Nanjing Vishee Medical Technology Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025. Review 688580 financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.69 Billion ≈ $247.75 Million	CN¥176.74 Million ≈ $25.86 Million	0.104x	+43.63%
2024-12-31	CN¥1.63 Billion ≈ $238.15 Million	CN¥118.29 Million ≈ $17.31 Million	0.073x	-11.90%
2023-12-31	CN¥1.63 Billion ≈ $238.05 Million	CN¥134.20 Million ≈ $19.64 Million	0.082x	+46.34%
2022-12-31	CN¥1.53 Billion ≈ $223.67 Million	CN¥86.17 Million ≈ $12.61 Million	0.056x	-45.08%
2021-12-31	CN¥1.53 Billion ≈ $224.34 Million	CN¥157.37 Million ≈ $23.03 Million	0.103x	+19.93%
2020-12-31	CN¥1.41 Billion ≈ $206.47 Million	CN¥120.76 Million ≈ $17.67 Million	0.086x	-84.58%
2019-12-31	CN¥254.86 Million ≈ $37.29 Million	CN¥141.47 Million ≈ $20.70 Million	0.555x	+26.84%
2018-12-31	CN¥196.16 Million ≈ $28.70 Million	CN¥85.84 Million ≈ $12.56 Million	0.438x	+28.26%
2017-12-31	CN¥153.42 Million ≈ $22.45 Million	CN¥52.35 Million ≈ $7.66 Million	0.341x	+30.17%
2016-12-31	CN¥118.20 Million ≈ $17.30 Million	CN¥30.98 Million ≈ $4.53 Million	0.262x	+10.44%
2015-12-31	CN¥106.25 Million ≈ $15.55 Million	CN¥25.22 Million ≈ $3.69 Million	0.237x	-2.51%
2014-12-31	CN¥61.64 Million ≈ $9.02 Million	CN¥15.01 Million ≈ $2.20 Million	0.243x	+14.83%
2013-12-31	CN¥38.81 Million ≈ $5.68 Million	CN¥8.23 Million ≈ $1.20 Million	0.212x	--

About Nanjing Vishee Medical Technology Co Ltd

SHG:688580 China Medical Devices

Market Cap

$676.05 Million

CN¥4.62 Billion CNY

Market Cap Rank

#10809 Global

#2931 in China

Share Price

CN¥48.24

Change (1 day)

-4.36%

52-Week Range

CN¥43.34 - CN¥69.70

All Time High

CN¥207.27